chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Later that night with headache non stop, heart was beating hard, calm with Excedrin . When eating felt like stomach and esophagus felt like acid, food and drink and water felt heavy and skin had hurt for clothing to touch.  4-5 days later called the doctor when the thought and stomach condition fail to subside.  Question and answer was gastrointestinal she wanted you take Prilosec for couple of days.  Work with the burning. Lasted about a week to a week in a half 9-10 days.  Felt dizzy and forgetful of basic words for  7 days.
pt became pale, weak, clammy while standing @ ck out, sat down on floor, did not lose cons was laid down & sniffed ammonia capsule, cool rag applied-BP 110/52; BP 110/64 p/8mins;
Client woke up on 01/06/2023 with Nausea, Headache, and sore throat.  Client states she had a fever of 100.9 degrees for 2 1/2 days.  roof of mouth felt like it had hives and her tongue swelled.  Client states she had loss of appetite and nausea.  Client states she has had sever fatigue that it finally starting to feel better today which is 6 days since symptoms started.
The patient's left arm was noted reddened, swollen and warm to the touch.  The patient stated that the swelling began after he recieved influenza and pnuemonia vaccines.
31 year old female received FLUVAC -Lot: AFLUA6898A; Exp: 06/26/2013-. Approximately 15 minutes later, the patient experienced throat tightness, chest pain, and exhibited altered mental status. 0.3 mg of EPIPEN was administered.  Patient was transferred to ER and given 50 mg of diphenhydramine PO, 60 mg of prednisone PO, and monitored with pulse ox and cardiac monitoring. Patient remained in ER for 6 hours before being discharged home by medical personnel.
Patient experienced light headedness and felt as if she was about to faint. she had to sit down on the floor because she could not stand. This occurred about 5 minutes after administration of the vaccine. prior to receiving the vaccine the patient stated that they have had a history of fainting when she sees needles. patient was offered water for hydration, and given a cold rag and water bottle to put on her face and neck. Patient was advised to sit with her chest down to her thighs. after about fifteen minutes the patient felt better and wanted to go home with her mother
pt recv vax in 1997 & devel vesicles @ the inj site;
Pt vax w/ 3 hepta B; pt did not respond.  Pt recd 3rd hepta B Nov90.  Booster dose given 07Jan91.
Nurse gave expired dose of Hepatitis B to patient. Expired on 11/12/22; given on 11/16/2022
Patient came in today (7/14/21) to receive 2nd dose of Moderna after receiving 1st dose on 6/14/21. Front staff and vaccinator did not notice she received Moderna and she was given a dose of Pfizer on accident. We monitored her for 20 minutes and she had no adverse reactions. She was advised by me not to receive a 2nd dose of Moderna or Pfizer. I explained how the MOA of both brands are similar. She was given our information to contact us with any questions or concerns.
Swelling around site, large circumference- 4-5" wide, raised area, painful on 7/27/18, nausea and close to vomiting by the evening. Morning of 7/28 patient woke up with a panic feeling, racing heart rate, trouble breathing (taking a deep breath), nausea and difficulty concentrating or finishing a sentence, trouble focusing on questions, "feeling ill and getting worse", chest tightness. Patient then called nurse advice and they said to go to urgent care for an EKG. This is all of the information this writer has at this time and I suspect primary care will also report to VAERS.
fever first noted 5 hrs p/vax; fever rose to 103.6 3 hrs later; pt floppy & unresponsive @ that time; 10 mins later parents noted generalized sz lasting 2-3 mins; pt remained sleepy for 3-4 hrs & then improved; also emesis x 3
8-17 pt got flu and pneumonia. 8/18 pt "had phlegm". 8-19 pt had cough. 8-24 went to PCP, put on OTC med and antibiotic, poss bronchitis.
One week following shot area scaling, then scabs for 3 weeks. Still has redness 1-2-08; small red area. No itching no fever, no aching.
Information has been received from a licensed practical nurse referring to a 61 year old female patient. The patient's concurrent condition and medical history were not reported. On 15-AUG-2015 the patient was vaccinated with the third dose of RECOMBIVAX HB (lot # L008660, expiration date 10-NOV-2015, dose and route were unknown), the patient was inadvertently administered the pediatric formulation rather than the adult formulation of the RECOMBIVAX HB. No adverse events were reported. Additional information has been requested.
Itching, redness on palms, light rash between fingers. Initially thought to be a reaction to dish soap since it occurred after washing dishes with different soap. Occurred in late afternoons, not every day. On 5/30/10 he had swelling of hands, intense itching and hives on chest. Took Benadryl. No symptoms since.
Fall; fatigued; arm pain; AML; Sepsis secondary to AML; This is a spontaneous report from a contactable consumer. An 88-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL3249), via an unspecified route of administration on 19Jan2021 17:30 in right arm at single dose for covid-19 immunization.  Medical history included hypertension, hyperlipidemia, OA (osteoarthritis), cognitive impairment. No other vaccine in four weeks was administrated.  Concomitant medication in two weeks included atorvastatin, aspirin, calcium, gabapentin, losartan and memantine hydrochloride (NAMENDA).  The patient previously took lisinopril and tetracycline and both experienced allergies. The patient had no covid prior vaccination. The patient initially had no symptoms but arm pain in Jan2021, no bleeding or bruising from injection. On 31Jan2021 19:00, patient felt fatigued. Patient suffered fall on 01Feb2021. She was admitted to hospital. All cell lines were down in Feb2021. She was diagnosed with AML (acute myeloid leukemia) in 2021. She expired 07Feb2021. Events resulted in emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event) and patient died. The patient received the treatment of blood and platelet transfusions, bone marrow biopsy, cytogenetic testing, antibiotics, intubation for events. The patient died on 07Feb2021 due to sepsis secondary to AML. An autopsy was not performed. Outcome of events were fatal.; Reported Cause(s) of Death: arm pain; fatigued; fall; Sepsis secondary to AML; Sepsis secondary to AML
I have experienced breakthrough vaginal bleeding for the first time in the 15 years I have been on birth control.  I am aware that they are looking at links between the vaccine and menstration and I wanted to share this abnormal event.
Client received 2nd dose of Moderna vax too early on 6/17/21.  First dose was on 6/2.  2nd due no sooner than 6/26-6/30/21
Uneasy feeling like restless leg syndrome but in entire body.; Uneasy feeling like restless leg syndrome but in entire body; Can not sleep; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 04:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), salbutamol (ALBUTEROL), atorvastatin (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. On 23Apr2021 at 22:30, the patient experienced uneasy feeling like restless leg syndrome but in entire body and she could not sleep because of it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Any therapeutic measures were not taken for the reported events. The clinical outcome of the events uneasy feeling like restless leg syndrome but in entire body and can not sleep was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Postural hypotension,tachycardia, changes in mentation. Patient had La Bicillin at the same visit.
02/02/22 presents to ED for "progressive leg swelling and concern for CHF given blood work showing elevated BNP". PMHx of "HTN, Type II DM, CKD S3, HLD"
SORE; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown and expiry unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient recovered from sore, and tired on APR-2021. This report was non-serious.
Burning sensation in outer edge of both eyes.   After initial injection in 1/5/21, I experienced this sensation in right eye only your about 7 days.  I will be seeing an ophthalmologist on2/19/21.  The sensation today, after the second shot is greater in intensity and affects both  eyes.
ACUTE NON ST ELEVATION MI 7/26/2021 DM 2 W ULCER OF LEFT FOOT ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 DM 2 W ULCER OF LEFT FOOT HYPOTENSION 7/26/2021 DM 2 W ULCER OF LEFT FOOT ACUTE NON ST ELEVATION MI 7/26/2021 DM 2 W PERIPHERAL VASCULAR DISEASE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 DM 2 W PERIPHERAL VASCULAR DISEASE HYPOTENSION 7/26/2021 DM 2 W PERIPHERAL VASCULAR DISEASE ACUTE NON ST ELEVATION MI 7/26/2021 GANGRENE OF LEFT TOE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 GANGRENE OF LEFT TOE HYPOTENSION 7/26/2021 GANGRENE OF LEFT TOE ACUTE NON ST ELEVATION MI 7/26/2021 GANGRENE OF LEFT FOOT ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 GANGRENE OF LEFT FOOT HYPOTENSION 7/26/2021 GANGRENE OF LEFT FOOT ACUTE NON ST ELEVATION MI 7/26/2021 LOWER GI HEMORRHAGE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 LOWER GI HEMORRHAGE HYPOTENSION 7/26/2021 LOWER GI HEMORRHAGE ACUTE NON ST ELEVATION MI 7/26/2021 LATE EFFECT OF STROKE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 LATE EFFECT OF STROKE HYPOTENSION 7/26/2021 LATE EFFECT OF STROKE ACUTE NON ST ELEVATION MI 7/26/2021 GANGRENE OF LEFT FOOT    PRESENCE OF GASTROSTOMY ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/26/2021 GANGRENE OF LEFT FOOT    PRESENCE OF GASTROSTOMY HYPOTENSION 7/26/2021 GANGRENE OF LEFT FOOT    PRESENCE OF GASTROSTOMY
Headache, Myalgia, Arthralgia, H/A arm pain muscle cramps hands and feet, neck  pain 2nd dose Narrative:
didn't get the 2nd; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st shot received on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: didn't get the 2nd). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 03-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the first shot of shingles vaccine but did not get the second. Additional Supportive Information:Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. The follow-up could not be possible as no contact details were available.
BLOOD CLOTS; This spontaneous report received from a consumer concerned female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration, and batch number were not reported, expiry: unknown) dose was not reported, 01 in total, administered on 26-JAN-2022 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in JAN-2022, the patient had blood clots. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220200866- COVID-19 VACCINE AD26.COV2.S- Blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Patient may have received first dose with a Pediatric (5 to 11 yo)  pfizer vaccine
Information has been received from a Nurse concerning a female who on 29-MAY-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 656923/0451U). On 29-MAY-2007, the patient received a second dose of varicella virus vaccine live (Oka/Merck) and experienced an injection site rash that measured 2" X 3" to 3" X 3" in diameter which was red, hot to the touch and swollen. Subsequently, the patient recovered from the injection site rash 2 days later after treatment with an antihistamine (therapy unspecified) and cold compresses. This is one of several reports received from the same source. Additional information is expected.
Enlarged lymph node in arm pit on left/right that disappeared then appeared on opposite arm, then disappeared again.
5 days after getting shot, daughter started displaying intense fatigue, joint pain, sore throat, cough and a rash on her neck. 3 weeks later symptoms remain. Extensive testing done, as well as Lymes. All is normal.
Event occurred after 2nd dose. Patient was diagnosed with COVID Tylenol Discharged to another facility
Severe headache at night, headache through out the day,  swelling  sensation of face, swelling around throat area,  swelling in the vaginal area, swelling of thighs, feeling  of pins and needles in throughout the body, pins and needles feeling  in the anal opening, loose bowel, first few days severe pain in the left arm., lack of appetite
Neck pain almost immediately after injection Abdominal cramping and diarrhea day after  Constant headache since 1 hour after vaccine to present day
Pt recvd dose of vax 21NOV92 & on 22NOV92 devel 2 to 3 inch swelling @ inject site, pain in the inject arm, pain & tingling in fingertips, muscle stiffness, hives & red spots @ the inject site; pt recovered; No further details were provided
Dizziness, nausea, lightheaded, passing out, fever, Achy muscles and joints, Fatigue, Headache, chills
Information has been received from a health professional concerning a 14 year old female who on 29-JAN-2008 was vaccinated with her third dose of GARDASIL (Lot #659653/1448U) in her right deltoid.  On 30-JAN-2008 the patient experienced a pimple at the injection site, and the whole deltoid swelled to 1 1/2 sizes larger than normal, and was warm to the touch.  The patient did not have a fever.  The patient sought unspecified medical treatment with a phone call and nurse states the patient will be seen for follow up.  The patient reports the symptoms are not resolved.  Follow-up information was received stating that upon evaluation, it was a local reaction.
Within one hour arm and shoulder pain. Unable to lift arm above shoulder. Pain while trying to undress, lift objects and most of all during sleeping time. Treatment with NSAIDS, ice, moist heat, cortisone shot and no improvement. (Diagnose as Bursitis).
Measles: skin erythema. Information has been received from a health care professional concerning a 42 year old caucasian male patient who on 11-Jun-1999 was vaccinated in the left arm with measles virus vaccine live (+) mumps virus live (+) rubella virus vaccine live (second generation). On 23-Jun-1999 the patient experienced a red rash on his stomach, legs, neck, and ears. The patient sought medical attention and was diagnosed with measles. Subsequently the patient recovered for the episodes. No further information is available.
Received vaccine on 10/13/03. Called on 10/15/03 that vaccine site swollen and red. Advised to take to PEDS ER. Mother called on 10/16/03 that child is admitted to hospital. Hospital record is received and lists a diagnosis of cellulitis for this event. She was treated w/ Ancef. There was no fever, no discharge. The induration measured 4 inches. Child was discharged on day 3 in stable condition.
Potential AE due to doses administered from vials that may have been compromised; Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion; Potential AE due to doses administered from vials that may have been compromised; This spontaneous case was reported by a pharmacist and describes the occurrence of IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Potential AE due to doses administered from vials that may have been compromised) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Potential AE due to doses administered from vials that may have been compromised). At the time of the report, IMMUNISATION REACTION (Potential AE due to doses administered from vials that may have been compromised), PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccines were stored in an unapproved freezer/some of the freezers there was a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Potential AE due to doses administered from vials that may have been compromised) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Moderna ordered date was 01-Nov-2021 and 15-Nov-2021 The beyond use date of the vaccines was reported as 01-Dec-2021 to 15-Dec-2021. No concomitant medications information was reported.  Reporter stated that they had a group of 13 pharmacies and had administered the Moderna vaccine. Their digital data loggers and freezers expired before they were re-calibrated. They were aware that in some of the freezers there was a temperature excursion that their data logs showed. The vaccines had never reached a temperature that was considered outside of frozen recommended range. The data loggers had laps where they were not considered calibrated, so they had paper logs to monitor those temperatures. This was in several different freezers and the vial temperatures never went out of range when they were using the paper log.  No treatment medications were provided.
Site: Swelling at Injection Site-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: high blood sugar reported-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: instructed to stay hydrated and constantly check BG and to visit the urgent care if feel worse. Reported AE started 2 days after the night of the shot. Also told us that usually after each vaccination her blood pressure shoots up
Pt received flu vaccine about 1:30pm 10/26/06. Wife called at 4:45pm states pt having hand tremors and temp 102. Went to home. Tylenol and Benadryl given Per wife. In one hour no improvement. 911 called. Pt transported to hospital ER via stretcher. PT started on IV antibiotics. Admitted to hospital x 5 days.  1/16/07 Received medical records from hospital which reveal patient was admitted to hospital 10/26/06 for neutropenia & fever within 24 hours s/p flu shot.  Heme consult done & treated w/Neupogen & antibiotics.  WBC improved & Neupogen was d/c.  Patient was to continue oral antibiotics &  f/u w/heme & oncologist upon d/c to home on 10/31/06.
Vaccine given 6/16/11. On 6/17/11 pt got a rash on (R) forehead, upper cheek & (R) scalp. Macular, papular red & swollen around (R) eye.
Information has been received from a registered nurse via a company representative, referring to a 12 month old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On an unknown date, the patient was vaccinated with a dose of PROQUAD (dose, anatomical location, administration route, lot number and expiration date were not reported); on the same date (in the same office visit), the patient was also vaccinated with a dose of VARIVAX (dose, anatomical location, administration route, lot number and expiration date were not reported) both vaccines as prophylaxis. No adverse events were reported.
This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS, BACK PAIN, EYE IRRITATION, BALANCE DISORDER, and NECK PAIN in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 06AE21N, 012120A, and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced BALANCE DISORDER, FEELING COLD, and CHILLS. On 28-Oct-2021, the patient experienced MUSCULOSKELETAL STIFFNESS, BACK PAIN, EYE IRRITATION, and HEADACHE. On 31-Oct-2021, the patient experienced NECK PAIN. On 29-Oct-2021, FEELING COLD, and CHILLS had resolved. On 30-Oct-2021, MUSCULOSKELETAL STIFFNESS, BACK PAIN, and HEADACHE had resolved. On 31-Oct-2021, NECK PAIN had resolved. On 01-Nov-2021, EYE IRRITATION and BALANCE DISORDER had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant drugs were reported.  Treatment reported were Eye wash/drops.
Patient c/o of rapid heart rate.  Skin warm and dry color good.  v/s, 146/80, HR 116 SAO2 100%.   Encouraged to relax. Teary, 106/63, HR 68 SAO2 100% at 15:35.   15:50, standing, 106/59, HR 81 SAO2 100%.Discharged with escort to front door.